PROGNOMIX
Prognomix is a private research-based company focused on the discovery of genetic signatures associated with the complications of Type II Diabetes. The company plans to develop and market molecular diagnostic kits for the testing of diabetes complications. The company is concentrating on developing a molecular diagnostic test pertinent for detection of risks to develop renal, ocular, cardiac, cerebral, vascular and other complications of diabetic disease. This market is vast and estimated to be around $24 billion in the United States alone.
PROGNOMIX
Industry:
Biotechnology Genetics
Founded:
2005-01-01
Address:
Çan, Canakkale, Turkey
Country:
Turkey
Website Url:
http://www.prognomix.com
Total Employee:
101+
Status:
Active
Contact:
514-529-9757
Email Addresses:
[email protected]
Total Funding:
4.1 M USD
Technology used in webpage:
Domain Not Resolving Gentoo Linux
Similar Organizations
Okairos
Okairos AG is a biopharmaceutical company focused on the discovery and development of genetic T-cell vaccines, including hepatitis C virus.
Current Advisors List
Investors List
Picchio Pharma
Picchio Pharma investment in Venture Round - Prognomix
BDC Venture Capital
BDC Venture Capital investment in Venture Round - Prognomix
